Efficacy and Safety of Camrelizumab Combination Therapy in Triple-Negative Breast Cancer
Camrelizumab combination therapy showed promising results in TNBC treatment, with good survival outcomes. Depending upon the outcomes of future phase III trials, factors influencing the efficacy of camrelizumab might be explored.
Authors
- Maheen Zahid
- Muhammad K. Amin
- Haider Ashfaq
- Zain A. Nadeem
- Umar Akram
- Hamza Ashraf
- Eeshal Fatima
- Moazzam Shahzad
- Rutaab Kareem
- Khawaja Abdul Rehman
- Obaid Ur Rehman
- Muhammad A. Raza
- Aimen Nadeem
Institutions
- Services Institute of Medical Sciences (PK)
- Liaquat University of Medical & Health Sciences (PK)
- King Edward Medical University (PK)
- Allama Iqbal Medical College (PK)
- CMH Lahore Medical College and Institute of Dentistry (PK)
- Moffitt Cancer Center (US)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1097/coc.0000000000001299
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00